CEREVEL THERAPEUTICS HLDNG I

CUSIP: 15678U128 Class: Common Stock

Frazier Life Sciences Management, L.P.'s Holding History (CIK: 0001892134)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 393,000 Value ($000) $16,070 Avg Close — Range —
Q1 2024
Shares 393,000 Value ($000) $16,612 Avg Close — Range —
Q4 2023
Shares 393,000 Value ($000) $16,663 Avg Close — Range —
Q3 2023
Shares 393,000 Value ($000) $8,579 Avg Close — Range —
Q2 2023
Shares 393,000 Value ($000) $12,493 Avg Close — Range —
Q1 2023
Shares 393,000 Value ($000) $9,585 Avg Close — Range —
Q4 2022
Shares 393,000 Value ($000) $12,395 Avg Close — Range —
Q3 2022
Shares 393,000 Value ($000) $11,106 Avg Close — Range —
Q2 2022
Shares 202,260 Value ($000) $5,348 Avg Close — Range —
Q1 2022
Shares 55,835 Value ($000) $1,955 Avg Close — Range —